Target intelligence / Profile preview

Ferric citrate transport system (Fec system)

Target
Fec system
Molecular classification
Transporter, TonB-dependent receptor, ABC transporter
01

Overview

The ferric citrate transport system (Fec system) is a multi-component, membrane-associated transporter complex found in Gram-negative bacteria (most notably E. coli) that mediates the uptake of iron in the form of ferric-citrate. It consists of an outer membrane TonB-dependent transporter (FecA), a periplasmic binding protein (FecB), inner membrane permease proteins (FecC/FecD), and a cytoplasmic ATPase (FecE). The system is tightly regulated by FecR, an inner membrane signal transducer, and FecI, a sigma factor controlling operon expression. The Fec system is essential for bacterial survival in iron-limited environments, is induced by ferric-citrate, and is a potential target for antibacterial strategies that disrupt bacterial iron acquisition. In summary, "Membrane-associated iron/citrate transport sites" refers most directly to the ferric citrate transport system (Fec system) found in bacteria, whose canonical molecular targets are well-defined proteins such as FecA, FecB, and associated ABC transporters, rather than a single receptor or transporter. The generic phrase is not the preferred canonical name for molecular targeting.

Other names
Fec systemFerric citrate uptake systemFecA (outer membrane transporter)FecB (periplasmic binding protein)FecC/FecD (membrane permease)FecE (ATPase)FecR (regulator)FecI (sigma factor)
02

Mechanism of action

Transport inhibition: Blocking the binding or translocation of ferric-citrate (e.g., iron chelators competitively inhibit the uptake of iron-citrate complexes) TonB/FecA disruption: Small molecules or antibodies interfering with TonB or FecA function inhibit energy transduction or substrate uptake

03

Biological functions

Iron uptake/transportCitrate transport (in association with iron)Transmembrane signal transduction
04

Disease associations

InfectionOther
05

Safety considerations

None directly associated with the target itself (as it is a bacterial system), but interference with bacterial iron acquisition can select for resistance, and targeting bacterial uptake inadvertently may cause iron deficiency in host/cellular models if not selective
06

Interacting drugs

None routinely used therapeutically; however, experimental agents can inhibit ferric iron uptake by chelating iron or by targeting TonB/FecA (e.g., siderophore mimetics, iron chelators, and select antibiotics can disrupt iron acquisition)
07

Biomarkers

fecA, fecB gene expression

Beyond the preview

Go deeper on Ferric citrate transport system (Fec system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferric citrate transport system (Fec system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call